Frontier Capital Management CO LLC Cytokinetics Inc Transaction History

Frontier Capital Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $5.01 Million - $7.16 Million	-140,053 Reduced 87.97%	19,161 $877,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $3.94 Million - $5.58 Million	102,355 Added 180.02%	159,214 $7.71 Million
Q2 2022 Jul 20, 2022	SELL	$33.93 - $48.92 $12 Million - $17.3 Million	-352,691 Reduced 86.12%	56,859 $2.23 Million
Q1 2022 Apr 14, 2022	SELL	$29.74 - $46.0 $7.47 Million - $11.6 Million	-251,265 Reduced 38.02%	409,550 $15.1 Million
Q4 2021 Jan 19, 2022	SELL	$34.35 - $46.38 $3.25 Million - $4.39 Million	-94,623 Reduced 12.53%	660,815 $30.1 Million
Q3 2021 Oct 19, 2021	BUY	$18.54 - $35.74 $14 Million - $27 Million	755,438 New	755,438 $27 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.